Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
12.00
+0.62 (5.45%)
At close: Mar 9, 2026, 4:00 PM EDT
12.00
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:11 PM EDT
Ekso Bionics Holdings Revenue
In the year 2025, Ekso Bionics Holdings had annual revenue of $12.80M, down -28.60%. Ekso Bionics Holdings had revenue of $3.14M in the quarter ending December 31, 2025, a decrease of -38.31%.
Revenue (ttm)
$12.80M
Revenue Growth
-28.60%
P/S Ratio
3.17
Revenue / Employee
$232,709
Employees
55
Market Cap
42.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.80M | -5.13M | -28.60% |
| Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
| Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
| Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
| Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.37M |
| Retractable Technologies | 37.90M |
| Bionano Genomics | 28.72M |
| Precision Optics Corporation | 24.42M |
| Jin Medical International | 20.69M |
| Nephros | 17.93M |
| Milestone Scientific | 8.93M |
| Femasys | 2.06M |
EKSO News
- 6 weeks ago - Ekso Bionics Prices $5.852 million Private Placement - GlobeNewsWire
- 2 months ago - Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale - GlobeNewsWire
- 3 months ago - Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System - GlobeNewsWire
- 4 months ago - Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 4 months ago - Ekso Bionics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Ekso Bionics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 months ago - Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow - GlobeNewsWire